Your session is about to expire
← Back to Search
In-Home Technology for Dementia Caregivers
N/A
Waitlist Available
Research Sponsored by University of California, Berkeley
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months to 6 months
Awards & highlights
Study Summary
This trial will develop a supportive technology to help reduce anxiety, burden, and loneliness for caregivers of people with Alzheimer's, dementia, or mild cognitive impairment. The technology will use wearable devices like Apple Watches.
Who is the study for?
This trial is for caregivers in the U.S. who speak English, live with a spouse or family member diagnosed with Alzheimer's, other dementias, or mild cognitive impairment, use smartphones regularly and have internet access. It excludes those caring for individuals with certain non-neurodegenerative conditions, major psychiatric disorders, metabolic disorders/major organ dysfunction, recent alcohol abuse/dependence, significant head trauma/MRI contraindications.Check my eligibility
What is being tested?
The study tests an in-home technology system designed to reduce anxiety and loneliness among caregivers of dementia patients by using wearable devices like Apple Watches. The goal is to develop and assess this supportive technology's effectiveness before commercialization.See study design
What are the potential side effects?
Since the intervention involves non-invasive technology such as wearables and does not include medication or medical procedures, no traditional side effects are expected. However, there may be privacy concerns or stress related to learning new technologies.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months to 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months to 6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change from 3 Months to 6 Months in Beck Anxiety Inventory (BAI)
Change from 3 Months to 6 Months in Center for Epidemiological Studies Depression Scale (CES-D)
Change from 3 Months to 6 Months in Revised Functional Limitations Battery
+7 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: In-Home Technology SystemExperimental Treatment1 Intervention
The full system [(a) 1 gateway that connects with home internet to communicate/control the equipment; (b) 5 indoor motion sensors; (c) 3 door/cabinet entry sensors; (d) 1 water leak sensor; (e) 1 "call for help" button; (f) 2 motion-activated LED night lights; (g) 1 Apple Watch to detect falls and activity outside the home] will be self-installed by caregivers (N=60) in their homes. Monitoring of sensors, provision of warnings, messaging, and social networking features will be activated remotely for those participants who have been randomly assigned to this arm. Participation will extend over a 6 month period with questionnaires (e.g., health and well-being) administered 3 times (at the time of installation and every 3 months thereafter).
Group II: Limited In-Home Technology SystemPlacebo Group1 Intervention
The full system [(a) 1 gateway that connects with home internet to communicate/control the equipment; (b) 5 indoor motion sensors; (c) 3 door/cabinet entry sensors; (d) 1 water leak sensor; (e) 1 "call for help" button; (f) 2 motion-activated LED night lights], with the exception of the Apple Watch that those in the experimental condition receive will be self-installed by caregivers (N=60) in their homes. Only monitoring of the water leak and associated warnings will be activated remotely for those participants who have been randomly assigned to this limited (sham comparator) arm.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
In-Home Technology System
2022
N/A
~130
Find a Location
Who is running the clinical trial?
University of California, San FranciscoOTHER
2,514 Previous Clinical Trials
15,244,328 Total Patients Enrolled
34 Trials studying Dementia
203,573 Patients Enrolled for Dementia
University of California, BerkeleyLead Sponsor
181 Previous Clinical Trials
720,919 Total Patients Enrolled
4 Trials studying Dementia
329 Patients Enrolled for Dementia
People Power CompanyIndustry Sponsor
4 Previous Clinical Trials
329 Total Patients Enrolled
4 Trials studying Dementia
329 Patients Enrolled for Dementia
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is enrollment in this experiment still available?
"Clinicaltrials.gov reports that this clinical trial is actively enrolling participants, with the first post made on October 1st 2022 and most recent update occurring August 16th of the same year."
Answered by AI
What is the aggregate enrollment of participants in this clinical trial?
"Affirmative. Information found on clinicaltrials.gov illustrates that this research project, initially shared on October 1st 2022, is currently recruiting patients for participation. This trial requires approximately 120 people from a single medical site to take part in the study."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger